Maladie pulmonaire obstructive chronique (MPOC) Traitement en République de Corée — Coûts 2026

South Korean clinics prioritise inhaled bronchodilators such as LABA and LAMA as the primary treatment for COPD. Specialists commonly use a stepwise approach to manage symptoms and prevent flare-ups. Modern techniques are available at KOIHA-accredited institutions like Naeun Hospital. These include stem cell therapy and biological immunotherapy.

• Primary medications: Doctors prescribe inhaled bronchodilators such as LAMA/LABA to open airways effectively.
• Advanced therapy: Government-designated centres offer regenerative treatments including stem cell and gene therapies.
• Diagnostic tools: Specialists use pulmonary function tests to monitor lung capacity and treatment response.
• Clinical expertise: Leading pulmonologists like Dr Lee Nagwon specialise in managing chronic lung diseases.

Bookimed Expert Insight: South Korea blends traditional internal medicine with regenerative research. Local clinics handle routine inhaler prescriptions. Meanwhile, institutions like Naeun Hospital are government-designated for regenerative medicine. This gives patients access to stem cell treatments alongside standard bronchodilators. It is a rare combination in most respiratory departments.

Patient Consensus: Patients find COPD care in South Korea highly efficient. They note that local internal medicine clinics provide quick assessments and affordable inhalers. For complex cases, moving to major hospitals is common. However, exercise and smoking cessation remain central to daily management.

COPD diagnosis in Korea requires a pulmonary function test at a specialist respiratory clinic. Specialist pulmonologists use spirometry to measure airflow after a bronchodilator. Diagnosis follows GOLD criteria. A ratio under 0.7 confirms airflow limitation. Testing is most frequent for adults over 40.

• Specialist consultation: Visit internal medicine clinics for initial assessment and pulmonology referrals.
• Spirometry testing: Use pulmonary function tests to measure exhalation volume and capacity.
• Clinical criteria: Doctors apply Global Initiative for Chronic Obstructive Lung Disease (GOLD) standards.
• Imaging scans: Providers use chest X-rays or CT scans to eliminate other conditions.

Bookimed Expert Insight: Korean respiratory care is highly centralised. Leading doctors like Dr Sang Heon Cho and Dr Lee Nagwon operate within major university-affiliated networks. Seeking treatment at accredited centres like NAEUN Hospital gives access to regenerative medicine and clinical research protocols not available in smaller primary clinics.

Patient Consensus: Patients emphasise that spirometry results are more definitive than X-rays. They advise waiting six weeks after a respiratory infection to ensure test accuracy. Bringing previous inhaler records and imaging results to original appointments in Korea helps doctors compare lung function trends immediately.

Specialists in South Korea commonly prescribe inhaled LABA–LAMA combinations as the first-choice treatment. These long-acting bronchodilators account for over 30% of local prescriptions. Hospitals also use triple therapies like Breztri Aerosphere for moderate-to-severe cases. Korean guidelines now focus on increasing inhaler use.

• Inhaled bronchodilators: LABA–LAMA blends with indacaterol or glycopyrronium are frequently used.
• Combination therapies: ICS–LABA inhalers help patients with asthma-like symptoms or eosinophilia.
• Triple therapy: Breztri Aerosphere combines budesonide, glycopyrronium, and formoterol for advanced cases.
• Oral medications: Doxofylline and systemic beta-agonists are still prescribed more than elsewhere.

Bookimed Expert Insight: Patients in Seoul benefit from rapid access to newly launched triple therapies. Major clinics like Asan Medical Center often participate in global respiratory trials. Large university hospitals serve over 100,000 patients annually. This volume ensures specialists are highly experienced with complex pharmaceutical adjustments.

Patient Consensus: Travellers find Korean specialists very thorough during initial lung function tests. Patients in South Korea appreciate the detailed inhaler training clinics provide. They are taught how to use new devices correctly.

Specialised pulmonary rehabilitation (PR) programs in Korea operate primarily within major university hospitals. These structured programs include breathing retraining, inspiratory muscle exercises, and aerobic training. Facilities like Gangnam Severance Hospital offer pioneering centres. Leading pulmonologists such as Dr Sang Heon Cho provide specialist care for chronic obstructive pulmonary disease (COPD).

• Certified facilities: NAEUN Hospital holds KOIHA accreditation. This means international standards for quality and safety.
• Expert leadership: Dr Lee Nagwon leads pulmonology in Incheon. He specialises in chronic lung diseases.
• Specialist research: Dr Hwang Dongin joins the COPD Research Group. He focuses on pulmonary intensive care.
• Regenerative medicine: Some Korean centres hold government designations. They conduct treatments in gene therapies.

Bookimed Expert Insight: University hospitals in Seoul, like Yonsei Severance, are pioneers. NAEUN Hospital in Incheon, however, offers a high-capacity alternative. It serves 500,000 patients annually and holds specific government designations for regenerative medicine. This suggests patients can find research-backed care outside the capital. They do not sacrifice quality-certified safety standards.

Patient Consensus: Patients with chronic lung conditions find structured hospital-based programs transformative for daily function. They suggest looking at large tertiary hospitals. That is because smaller clinics rarely offer the necessary specialised respiratory equipment.

South Korea National Health Insurance Service (NHIS) covers essential COPD treatment. Coverage includes outpatient visits, hospitalisations, pulmonary function tests, and rehabilitation. Specialists at centres like NAEUN Hospital provide these services. Patients typically pay co-payments ranging from 30% to 60% of total costs.

• Medication coverage: NHIS reimburses standard bronchodilators based on lung function test results.
• Oxygen therapy: Insurance covers both home and portable oxygen for eligible patients.
• Rehabilitation services: Personalised exercise programs have been included in national coverage since 2017.
• Quality oversight: Government bodies audit clinics regularly to maintain appropriate respiratory care standards.

Bookimed Expert Insight: While NHIS covers standard care, patients often choose private clinics for specialised pulmonary intensive care. Senior pulmonologists like Dr Lee Nagwon and Dr Hwang Dongin at NAEUN Hospital lead these departments. This hospital also holds a government designation for advanced regenerative therapies. This allows them to offer treatments beyond standard protocols. However, these may fall outside basic NHIS coverage.

Patient Consensus: Patients find standard COPD care costs manageable under the co-pay system in South Korea. They note that costs vary between small clinics and large hospitals. They recommend the NHIS English centre to confirm coverage for specific inhalers or imaging tests.

South Korean pulmonology specialists are found at major university hospitals in Seoul and Incheon. Leading experts include Dr Sang Heon Cho and Dr Lee Nagwon. These specialists hold international certifications. They effectively manage chronic lung conditions with diagnostics like low-dose chest CT and bronchial endoscopy.

• Expert specialists: Dr Sang Heon Cho has over 40 years of respiratory medicine experience.
• Clinical excellence: Gwangdong Hospital holds a World Allergy Organization Center of Excellence designation.
• Credentialed care: Dr Lee Nagwon is a full member of the Korean Academy of Tuberculosis.
• Specialised treatments: Clinics offer bronchoscopic balloon dilatation and regenerative medicine for COPD.

Bookimed Expert Insight: While top-tier university hospitals provide high-level care, NAEUN HOSPITAL in Incheon serves 500,000 patients annually. It holds government designation for regenerative medicine. This suggests that patients can access sophisticated gene and stem cell therapies for COPD outside the busiest Seoul centres. They often experience shorter wait times for diagnostic testing.

Patient Consensus: Patients recommend visiting a major hospital for serious respiratory issues rather than local clinics. They suggest requesting both pulmonary function tests and CT scans to confirm diagnoses. They also recommend using international clinics for English-speaking support.